drugset / Trial / NCT00388505
Safety of Tobramycin Inhalation Powder (TIP) vs Tobramycin Solution for Inhalation in Patients With Cystic Fibrosis
RandomizedParallel-groupOpen-labelTreatment
Summary
This study compares the safety of the tobramycin solution for inhalation with the tobramycin dry powder formulation, used with a simple inhaler
Timeline
- Start
- 2006-02
- Primary completion
- 2009-03
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tobramycin | Small molecule | 112 mg | Inhaled |
| Subject | Tobramycin | Small molecule | 300 mg | Inhaled |